Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hara

Showing results (751-760 of 1,319) with videos related to

Pageof 132
Sort By:
Immunology Letters|August 1, 1993
A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAFT Hara, M Matsumoto, Y Fukumori, et al.
Biochimica Et Biophysica Acta|January 12, 1996
Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomesT Hara, H Kuwasawa, Y Aramaki, et al.
Cancer Research|March 15, 1991
Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicityT Taki, K Ogura, C Rokukawa, et al.
Caries Research|August 20, 2003
Caries progression and inhibition in human and bovine root dentine in situA T Hara, C S Queiroz, A F Paes Leme, et al.
Neuropediatrics|August 30, 2000
A case of Høyeraal-Hreidarsson syndrome: delayed myelination and hypoplasia of corpus callosum are other important signsS Akaboshi, M Yoshimura, T Hara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 25, 1999
[Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]Y Shimomura, H Tsurumi, M Sawada, et al.
Cancer Letters|April 11, 2001
Quick quantitative analysis of gene dosages associated with prognosis in neuroblastomaT Tajiri, S Tanaka, K Shono, et al.
American Journal of Hematology|July 27, 2000
Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphomaT Hara, H Tsurumi, M Takemura, et al.
Molecular and Cellular Endocrinology|February 13, 2001
Interleukin-6 decreases estrogen production and messenger ribonucleic acid expression encoding aromatase during in vitro cytodifferentiation of rat granulosa cellK Tamura, T Kawaguchi, T Hara, et al.
Experimental and Clinical Immunogenetics|November 30, 2000
Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese populationF Nakao, K Ihara, S Ahmed, et al.
Pageof 132

Showing results (751-760 of 1,319) with videos related to

Sort By:
Pageof 132
Immunology Letters|August 1, 1993
A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAFT Hara, M Matsumoto, Y Fukumori, et al.
Biochimica Et Biophysica Acta|January 12, 1996
Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomesT Hara, H Kuwasawa, Y Aramaki, et al.
Cancer Research|March 15, 1991
Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicityT Taki, K Ogura, C Rokukawa, et al.
Caries Research|August 20, 2003
Caries progression and inhibition in human and bovine root dentine in situA T Hara, C S Queiroz, A F Paes Leme, et al.
Neuropediatrics|August 30, 2000
A case of Høyeraal-Hreidarsson syndrome: delayed myelination and hypoplasia of corpus callosum are other important signsS Akaboshi, M Yoshimura, T Hara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 25, 1999
[Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma]Y Shimomura, H Tsurumi, M Sawada, et al.
Cancer Letters|April 11, 2001
Quick quantitative analysis of gene dosages associated with prognosis in neuroblastomaT Tajiri, S Tanaka, K Shono, et al.
American Journal of Hematology|July 27, 2000
Serum-soluble fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphomaT Hara, H Tsurumi, M Takemura, et al.
Molecular and Cellular Endocrinology|February 13, 2001
Interleukin-6 decreases estrogen production and messenger ribonucleic acid expression encoding aromatase during in vitro cytodifferentiation of rat granulosa cellK Tamura, T Kawaguchi, T Hara, et al.
Experimental and Clinical Immunogenetics|November 30, 2000
Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese populationF Nakao, K Ihara, S Ahmed, et al.
Pageof 132